Contributed by Jessica Taaffe:

Ever wonder what global health research opportunities are available for biomedical scientists?  Interested in how international field clinical and research sites are set up?  HIV and STD expert Dr. Thomas Quinn will discuss these topics in an upcoming seminar at NIH on May 28, hosted by the NIH Global Health Interest Group.  Dr. Quinn is an excellent speaker, has a wealth of international HIV research experience, and has been involved in global health activities at Johns Hopkins Bloomberg School of Public Health and at NIH.  See more information below:

The Global Health Interest Group presents:

“International HIV Research: Past, Present and Future Global Health Research Opportunities”

Thomas Quinn, MD, MSc

Associate Director for International Research, Chief of International HIV/STD Research

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases

NIH

Tuesday, May 28th, 2013

11am –  noon

National Institutes of Health (9000 Rockville Pike, Bethesda, MD)

Building 50, Rm 1328/1334 Rear

(Non-NIH badge holders, please go check-in at NIH Visitor Center first with your gov’t issued ID)

Thomas C. Quinn, M.D., M.Sc. is Associate Director for International Research and Senior Investigator and Section Chief of International HIV/STD Research in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases.  Since 1981, he has been assigned to The Johns Hopkins University School of Medicine where he is a Professor of Medicine and Pathology, and has adjunct appointments in the Departments of International Health, Epidemiology, and Molecular Microbiology and Immunology in The Johns Hopkins Bloomberg School of Public Health. In 2006 he was appointed Director of the Johns Hopkins Center for Global Health.

Dr. Quinn’s investigations have involved the study of the epidemiologic, virologic, immunologic features of HIV infection in Africa, the Caribbean, South America and Asia.  In 1983 he led the first group of scientists to Haiti and central Africa to determine the extent of HIV within those countries.  In 1984, he helped establish the interagency project called “Projet SIDA” in Kinshasa, Zaire which was the largest AIDS investigative project in sub-Saharan Africa.  Since then he has generated numerous global initiatives and research programs in 28 countries.  He was among the first to describe the heterosexual transmission of HIV in Haiti, Zaire, Kenya, India, and more recently, China. He demonstrated that HIV viral load was the single most important predictor of HIV perinatal and sexual transmission, correlating this with timing of infection and natural history.  More recent collaborative studies in Uganda have also provided evidence that male circumcision can reduce HIV acquisition by at least 50%. He is currently the Principal Investigator of the NIAID International Center for Excellence in Research (ICER) in Uganda where he is conducting several studies on HIV pathogenesis, transmission, molecular epidemiology and response to therapy.

Dr. Quinn will discuss opportunities for biomedical scientists to get involved in global health research and touch on his experience setting up international field sites.

 

Check out upcoming seminars hosted by the NIH Global Health Interest Group here.